These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35536579)

  • 1. Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial.
    Luepker RV; Eder M; Finnegan JR; Van't Hof JR; Oldenburg N; Duval S
    JAMA Netw Open; 2022 May; 5(5):e2211107. PubMed ID: 35536579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016.
    Mufarreh A; Shah AJ; Vaccarino V; Kulshreshtha A
    JAMA Netw Open; 2023 Jan; 6(1):e2251156. PubMed ID: 36656581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.
    Van't Hof JR; Duval S; Walts A; Kopecky SL; Luepker RV; Hirsch AT
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-based group randomized trial to increase aspirin use for primary prevention of cardiovascular disease: Study protocol and baseline results for the "Ask About Aspirin" initiative.
    Duval S; Van't Hof JR; Oldenburg NC; Eder M; Finnegan JR; Luepker RV
    Contemp Clin Trials Commun; 2021 Jun; 22():100772. PubMed ID: 34027223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting Aspirin Use for Cardiovascular Disease Prevention Among an Adult Internet-Using Population: A Pilot Study.
    Oldenburg NC; Horvath KJ; Van't Hof J; Misialek JR; Hirsch AT
    Front Public Health; 2021; 9():500296. PubMed ID: 33796492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Preventive Aspirin Among Older US Adults With and Without Diabetes.
    Liu EY; Al-Sofiani ME; Yeh HC; Echouffo-Tcheugui JB; Joseph JJ; Kalyani RR
    JAMA Netw Open; 2021 Jun; 4(6):e2112210. PubMed ID: 34152419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Use and Misuse for the Primary Prevention of Cardiovascular Diseases.
    Luepker RV; Oldenburg NC; Misialek JR; Van't Hof JR; Finnegan JR; Eder M; Duval S
    Am J Prev Med; 2021 Apr; 60(4):513-519. PubMed ID: 33549391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.
    Oldenburg NC; Duval S; Luepker RV; Finnegan JR; LaMarre H; Peterson KA; Zantek ND; Jacobs G; Straka RJ; Miller KH; Hirsch AT
    Prev Chronic Dis; 2014 May; 11():E83. PubMed ID: 24831287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study].
    Zhang ML; Liu QP; Gong C; Wang JM; Zhou TJ; Liu XF; Shen P; Lin HB; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):480-487. PubMed ID: 37291924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial.
    Bardach NS; Wang JJ; De Leon SF; Shih SC; Boscardin WJ; Goldman LE; Dudley RA
    JAMA; 2013 Sep; 310(10):1051-9. PubMed ID: 24026600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.
    Gallagher H; Dumbleton J; Maishman T; Whitehead A; Moore MV; Fuat A; Fitzmaurice D; Henderson RA; Lord J; Griffith KE; Stevens P; Taal MW; Stevenson D; Fraser SD; Lown M; Hawkey CJ; Roderick PJ
    Trials; 2022 Apr; 23(1):331. PubMed ID: 35449015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?
    Fiscella K; Winters PC; Mendoza M; Noronha GJ; Swanger CM; Bisognano JD; Fortuna RJ
    J Gen Intern Med; 2015 Feb; 30(2):155-60. PubMed ID: 25092016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
    Mora S; Manson JE
    JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
    Fowkes FG; Price JF; Stewart MC; Butcher I; Leng GC; Pell AC; Sandercock PA; Fox KA; Lowe GD; Murray GD;
    JAMA; 2010 Mar; 303(9):841-8. PubMed ID: 20197530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial.
    Neprash HT; Vock DM; Hanson A; Elert B; Short S; Karaca-Mandic P; Rothman AJ; Melton GB; Satin D; Markowitz R; Golberstein E
    JAMA Health Forum; 2022 Jun; 3(6):e221852. PubMed ID: 35977248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    Dehmer SP; O'Keefe LR; Evans CV; Guirguis-Blake JM; Perdue LA; Maciosek MV
    JAMA; 2022 Apr; 327(16):1598-1607. PubMed ID: 35471506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.